OIM
OMGA

Oracle Investment Management’s Omega Therapeutics, Inc. Common Stock OMGA Stock Holding History

Oracle Investment Management’s Portfolio OMGA Stock Details OMGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-50,000
Closed -$108K – 30
2023
Q3 		$108K Sell
50,000
-147,449
-75% -$589K 0.03% 20
2023
Q2 		$1.11M Sell
197,449
-136,387
-41% -$1.07M 0.81% 20
2023
Q1 		$2.01M Buy
+333,836
New +$2.32M 1.95% 13

Other funds holding OMGA

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Oracle Investment Management's OMGA Position: Q4 2023 in Review

Oracle Investment Management sold out of Omega Therapeutics, Inc. Common Stock (OMGA) in Q4 2023, closing a stake of 50,000 shares — an estimated $108K sold.

Oracle Investment Management first reported a position in OMGA in Q1 2023 and held it in 3 quarters. The position peaked at $2.01M in Q1 2023. 63 funds tracked by Wall St. Rank hold OMGA as of Q4 2023.

  • Oracle Investment Management reported no remaining Omega Therapeutics, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Oracle Investment Management sold 50,000 Omega Therapeutics, Inc. Common Stock shares in Q4 2023, an estimated $108K.
  • Oracle Investment Management first reported a position in Omega Therapeutics, Inc. Common Stock in Q1 2023 and held it in 3 quarters.
  • Oracle Investment Management's Omega Therapeutics, Inc. Common Stock position peaked at $2.01M in Q1 2023.
  • 63 funds tracked by Wall St. Rank held Omega Therapeutics, Inc. Common Stock as of Q4 2023.

Based on Oracle Investment Management's 13F filing for Q4 2023, filed 14 Feb 2024.